1-[4-(benzylamino)-6,8,9,10,11,11a-hexahydro-5H-pyrimido[4,5-a]quinolizin-2-yl]-2-methylindole-4-carbonitrile;1-[4-(benzylamino)-6,8,9,10,11,11a-hexahydro-5H-pyrimido[4,5-a]quinolizin-2-yl]-2-methylindole-4-carboxamide
C56H58N12O — CID 159424791
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[4-(benzylamino)-6,8,9,10,11,11a-hexahydro-5H-pyrimido[4,5-a]quinolizin-2-yl]-2-methylindole-4-carbonitrile;1-[4-(benzylamino)-6,8,9,10,11,11a-hexahydro-5H-pyrimido[4,5-a]quinolizin-2-yl]-2-methylindole-4-carboxamide
1-[4-(benzylamino)-6,8,9,10,11,11a-hexahydro-5H-pyrimido[4,5-a]quinolizin-2-yl]-2-methylindole-4-carbonitrile;1-[4-(benzylamino)-6,8,9,10,11,11a-hexahydro-5H-pyrimido[4,5-a]quinolizin-2-yl]-2-methylindole-4-carboxamide (PubChem CID 159424791) has the molecular formula C56H58N12O and a molecular weight of 915.16 g/mol. Its IUPAC name is 1-[4-(benzylamino)-6,8,9,10,11,11a-hexahydro-5H-pyrimido[4,5-a]quinolizin-2-yl]-2-methylindole-4-carbonitrile;1-[4-(benzylamino)-6,8,9,10,11,11a-hexahydro-5H-pyrimido[4,5-a]quinolizin-2-yl]-2-methylindole-4-carboxamide.
Molecular Properties
| Compound Name | 1-[4-(benzylamino)-6,8,9,10,11,11a-hexahydro-5H-pyrimido[4,5-a]quinolizin-2-yl]-2-methylindole-4-carbonitrile;1-[4-(benzylamino)-6,8,9,10,11,11a-hexahydro-5H-pyrimido[4,5-a]quinolizin-2-yl]-2-methylindole-4-carboxamide |
|---|---|
| PubChem CID | 159424791 |
| Molecular Formula | C56H58N12O |
| Molecular Weight | 915.16 g/mol |
| Exact Mass | 914.49 |
| IUPAC Name | 1-[4-(benzylamino)-6,8,9,10,11,11a-hexahydro-5H-pyrimido[4,5-a]quinolizin-2-yl]-2-methylindole-4-carbonitrile;1-[4-(benzylamino)-6,8,9,10,11,11a-hexahydro-5H-pyrimido[4,5-a]quinolizin-2-yl]-2-methylindole-4-carboxamide |
| SMILES | Cc1cc2c(C#N)cccc2n1-c1nc(NCc2ccccc2)c2c(n1)C1CCCCN1CC2.Cc1cc2c(C(N)=O)cccc2n1-c1nc(NCc2ccccc2)c2c(n1)C1CCCCN1CC2 |
| InChI | InChI=1S/C28H30N6O.C28H28N6/c1-18-16-22-20(26(29)35)10-7-12-23(22)34(18)28-31-25-21(13-15-33-14-6-5-11-24(25)33)27(32-28)30-17-19-8-3-2-4-9-19;1-19-16-23-21(17-29)10-7-12-24(23)34(19)28-31-26-22(13-15-33-14-6-5-11-25(26)33)27(32-28)30-18-20-8-3-2-4-9-20/h2-4,7-10,12,16,24H,5-6,11,13-15,17H2,1H3,(H2,29,35)(H,30,31,32);2-4,7-10,12,16,25H,5-6,11,13-15,18H2,1H3,(H,30,31,32) |
| InChIKey | LQFGHZMULPPUDH-UHFFFAOYSA-N |
| XLogP | 9.82 |
| TPSA | 158.84 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 69 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 915.16 |
| LogP ≤ 5 | 9.82 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159424791 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.